Bio-Tech & Science Related News

  • Super-radiance to unlock super-resolution imaging
    To this end, the team from Rice University, Texas and Texas A&M University has received a $1.2m award from the W.M. Keck Foundation to investigate super-radiance’s potential for research and innovation in medicine, engineering and the physical sciences. Super-resolution imaging (SRI) and single-molecule tracking (SMT) allow scientists to observe molecular-scale processes with extraordinary detail, but these
  • Everything you need to know about Stargate
    On President Donald Trump’s second day in office, he helped announce a private artificial intelligence venture that he said would be “the largest AI infrastructure project by far in history.”The Stargate Project, as the venture is named, is a partnership between four notable companies: OpenAI, SoftBank, Oracle and MGX. Its goal is to construct sites
  • Neurobots could help treat epilepsy
    Project NEUROBOT is one of 18 sharing £69m over four years in new funding announced yesterday (January 20, 225) from ARIA’s Precision Neurotechnologies programme. The NEUROBOT team will work to develop advanced, injectable neural robots, or ‘neurobots’, to deliver a treatment called closed-loop neuromodulation as an epilepsy treatment. Closed-loop neuromodulation works by closely monitoring brain
  • Conglomerated Imiquimod and Metronidazole Incorporated Biodegradable Nanofibrous Mats for Potential Therapy of Cervical Cancer
    Introduction Cervical carcinoma is one of the most common gynecological cancers worldwide, accounting for approximately 12% of all carcinomas in women.1 It originates from abnormal cell growth in the cervix and has the potential to invade or metastasize to other parts of the body. In the early stages, cervical carcinoma often presents no noticeable symptoms,
  • Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market
    publication date: Jan 20, 2025  |  author/source: Abselion Ruizhi Wang, CEO, Abselion with the Amperia at-line protein analyser. Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market. This cutting-edge benchtop instrument allows scientists to easily quantify